Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction
- 502 Downloads
Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.
KeywordsCystic fibrosis Lung transplantation Venovenous extracorporeal membrane oxygenation Preventative Primary graft dysfunction Protective
Conflict of interest
There is no conflict of interest or disclosure for any of the authors with any companies/organizations whose products/services discussed in this manuscript.
- 3.Turner DA, Cheifetz IM, Rehder KJ, Williford WL, Bonadonna D, Banuelos SJ, Peterson-Carmichael S, Lin SS, Davis RD, Zaas D. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med. 2011;39:2593–8.PubMedGoogle Scholar
- 7.Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D, ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT working group on primary lung graft dysfunction part ii: definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2005;24:1454–9.PubMedCrossRefGoogle Scholar
- 15.Fischer S, Bohn D, Rycus P, Pierre AF, de Perrot M, Waddell TK, Keshavjee S. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant. 2007;26:472–7.PubMedCrossRefGoogle Scholar